{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:34:32Z","timestamp":1792974872056,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.4065\/mcp.2009.0649","type":"journal-article","created":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T02:27:45Z","timestamp":1267410465000},"page":"S3-S14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1053,"special_numbering":"S","title":["Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update"],"prefix":"10.4065","volume":"85","author":[{"given":"Robert H.","family":"Dworkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec B.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Audette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey K.","family":"Gourlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija L.","family":"Haanp\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel L.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot J.","family":"Krane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa A.","family":"LeBel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean C.","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Miaskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa N.","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Schmader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Stacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Stanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf-Detlef","family":"Treede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis C.","family":"Turk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Walco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.4065\/mcp.2009.0649_bib1","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"issue":"6","key":"10.4065\/mcp.2009.0649_bib2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jpain.2005.01.359","article-title":"Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey","volume":"6","author":"Oster","year":"2005","journal-title":"J Pain"},{"issue":"12","key":"10.4065\/mcp.2009.0649_bib3","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jpain.2006.04.013","article-title":"Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives","volume":"7","author":"Gore","year":"2006","journal-title":"J Pain"},{"issue":"2","key":"10.4065\/mcp.2009.0649_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejpain.2005.01.014","article-title":"The burden of neuropathic pain: results of a cross-sectional survey","volume":"10","author":"McDermott","year":"2006","journal-title":"Eur J Pain"},{"issue":"15","key":"10.4065\/mcp.2009.0649_bib5","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1212\/01.wnl.0000259085.61898.9e","article-title":"The impact of neuropathic pain on health-related quality of life: review and implications","volume":"68","author":"Jensen","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.4065\/mcp.2009.0649_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00019053-200927020-00002","article-title":"Neuropathic pain: a review of the quality of life impact, costs, and cost-effectiveness of therapy","volume":"27","author":"O'Connor","year":"2009","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.4065\/mcp.2009.0649_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jpain.2003.12.004","article-title":"Clinical characteristics and economic costs of patients with painful neuropathic disorders","volume":"5","author":"Berger","year":"2004","journal-title":"J Pain"},{"issue":"8","key":"10.4065\/mcp.2009.0649_bib8","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1532-5415.2007.01231.x","article-title":"Health care costs of acute and chronic pain associated with a diagnosis of herpes zoster","volume":"55","author":"Dworkin","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"10.4065\/mcp.2009.0649_bib9","doi-asserted-by":"crossref","unstructured":"Dworkin RH, Malone DC, Panarites CJ, Armstrong EP, Pham SV. Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs [published online ahead of print October 21, 2009]. J Pain. doi:10.1016\/j.jpain. 2009.08.005.","DOI":"10.1016\/j.jpain.2009.01.075"},{"issue":"9","key":"10.4065\/mcp.2009.0649_bib10","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.vaccine.2008.12.024","article-title":"Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales","volume":"27","author":"van Hoek","year":"2009","journal-title":"Vaccine"},{"key":"10.4065\/mcp.2009.0649_bib11","series-title":"The 2008 report of the Chief Medical Officer:150 years of the Annual Report of the Chief Medical Officer: on the state of public health 2008","author":"Donaldson Sir","year":"2009"},{"issue":"3","key":"10.4065\/mcp.2009.0649_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"issue":"11","key":"10.4065\/mcp.2009.0649_bib13","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.4065\/mcp.2009.0649_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2007\/730785","article-title":"Pharmacological management of chronic neuropathic pain\u2014consensus statement and guidelines from the Canadian Pain Society","volume":"12","author":"Moulin","year":"2007","journal-title":"Pain Res Manag"},{"issue":"10A","key":"10.4065\/mcp.2009.0649_bib15","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.04.007","article-title":"Treatment of neuropathic pain: an overview of recent guidelines","volume":"122","author":"O'Connor","year":"2009","journal-title":"Am J Med"},{"issue":"2","key":"10.4065\/mcp.2009.0649_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pain.2008.01.006","article-title":"Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion?","volume":"138","author":"Attal","year":"2008","journal-title":"Pain"},{"issue":"1-2","key":"10.4065\/mcp.2009.0649_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pain.2009.06.001","article-title":"A cross sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory systems","volume":"146","author":"Baron","year":"2009","journal-title":"Pain"},{"key":"10.4065\/mcp.2009.0649_bib18","author":"CEBM Centre for Evidence-based Medicine"},{"issue":"10","key":"10.4065\/mcp.2009.0649_bib19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1468-1331.2008.02185.x","article-title":"AAN-EFNS guidelines on trigeminal neuralgia management","volume":"15","author":"Cruccu","year":"2008","journal-title":"Eur J Neurol"},{"issue":"15","key":"10.4065\/mcp.2009.0649_bib20","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1212\/01.wnl.0000326598.83183.04","article-title":"Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies","volume":"71","author":"Gronseth","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.4065\/mcp.2009.0649_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"issue":"4","key":"10.4065\/mcp.2009.0649_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.37.4.589","article-title":"Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood","volume":"37","author":"Max","year":"1987","journal-title":"Neurology"},{"issue":"1","key":"10.4065\/mcp.2009.0649_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/jpm.2006.9.29","article-title":"Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain","volume":"9","author":"Raskin","year":"2006","journal-title":"J Palliat Med"},{"issue":"5","key":"10.4065\/mcp.2009.0649_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00002018-200730050-00007","article-title":"An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies","volume":"30","author":"Wernicke","year":"2007","journal-title":"Drug Saf"},{"issue":"3","key":"10.4065\/mcp.2009.0649_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/17425255.4.3.281","article-title":"The hepatic safety profile of duloxetine: a review","volume":"4","author":"McIntyre","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"10.4065\/mcp.2009.0649_bib26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","article-title":"Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study","volume":"110","author":"Rowbotham","year":"2004","journal-title":"Pain"},{"issue":"12","key":"10.4065\/mcp.2009.0649_bib27","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1176\/ajp.154.12.1760","article-title":"Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine","volume":"154","author":"Fava","year":"1997","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.4065\/mcp.2009.0649_bib28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jpain.2008.05.014","article-title":"Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief","volume":"9","author":"Stacey","year":"2008","journal-title":"J Pain"},{"issue":"6","key":"10.4065\/mcp.2009.0649_bib29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00415-005-0717-z","article-title":"Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin","volume":"252","author":"Wasner","year":"2005","journal-title":"J Neurol"},{"issue":"1","key":"10.4065\/mcp.2009.0649_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mus.20419","article-title":"Skin biopsy and quantitative sensory testing do not predict response to the lidocaine patch in painful neuropathies","volume":"33","author":"Herrmann","year":"2006","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.4065\/mcp.2009.0649_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/ALN.0b013e31817f4523","article-title":"Morphine versus mexiletine for treatment of postamputation pain","volume":"109","author":"Wu","year":"2008","journal-title":"Anesthesiology"},{"issue":"7","key":"10.4065\/mcp.2009.0649_bib32","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"key":"10.4065\/mcp.2009.0649_bib33","series-title":"Recommendations for the appropriate use of opioids for persistent non-cancer pain","author":"British Pain Society","year":"2005"},{"issue":"5","key":"10.4065\/mcp.2009.0649_bib34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ejpain.2006.08.004","article-title":"Addiction to opioids in chronic pain patients: a literature review","volume":"11","author":"H\u00f8jsted","year":"2007","journal-title":"Eur J Pain"},{"issue":"2","key":"10.4065\/mcp.2009.0649_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"},{"issue":"4","key":"10.4065\/mcp.2009.0649_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/01.wnl.0000275528.01263.6c","article-title":"Clinical trial outcome in neuropathic pain: relationship to study characteristics","volume":"70","author":"Katz","year":"2008","journal-title":"Neurology"},{"issue":"1-2","key":"10.4065\/mcp.2009.0649_bib37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2007.06.033","article-title":"Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen","volume":"136","author":"Vranken","year":"2008","journal-title":"Pain"},{"issue":"3","key":"10.4065\/mcp.2009.0649_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/AJP.0b013e31818a744d","article-title":"Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial","volume":"25","author":"Norrbrink","year":"2009","journal-title":"Clin J Pain"},{"issue":"1","key":"10.4065\/mcp.2009.0649_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pain.2007.08.024","article-title":"Pain associated with multiple sclerosis: systematic review and proposed classification","volume":"137","author":"O'Connor","year":"2008","journal-title":"Pain"},{"issue":"12","key":"10.4065\/mcp.2009.0649_bib40","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncpneuro0949","article-title":"Should cannabinoids be used as analgesics for neuropathic pain?","volume":"4","author":"Rice","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"issue":"1-2","key":"10.4065\/mcp.2009.0649_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pain.2006.10.030","article-title":"Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin","volume":"130","author":"Tugnoli","year":"2007","journal-title":"Pain"},{"issue":"3","key":"10.4065\/mcp.2009.0649_bib42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.21427","article-title":"Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain","volume":"64","author":"Ranoux","year":"2008","journal-title":"Ann Neurol"},{"issue":"17","key":"10.4065\/mcp.2009.0649_bib43","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","article-title":"Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial","volume":"72","author":"Yuan","year":"2009","journal-title":"Neurology"},{"key":"10.4065\/mcp.2009.0649_bib44","author":"European Medicines Agency"},{"issue":"12","key":"10.4065\/mcp.2009.0649_bib45","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S1474-4422(08)70228-X","article-title":"NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study","volume":"7","author":"Backonja","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.4065\/mcp.2009.0649_bib46","author":"Qutenza (NGX-4010)"},{"issue":"24","key":"10.4065\/mcp.2009.0649_bib47","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1212\/01.wnl.0000314647.35825.9c","article-title":"Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"issue":"pt 7","key":"10.4065\/mcp.2009.0649_bib48","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/brain\/awh175","article-title":"The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy","volume":"127","author":"Polydefkis","year":"2004","journal-title":"Brain"},{"issue":"pt 9","key":"10.4065\/mcp.2009.0649_bib49","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/brain\/124.9.1754","article-title":"Roles of capsaicin-in-sensitive nociceptors in cutaneous pain and secondary hyperalgesia","volume":"124","author":"Magerl","year":"2001","journal-title":"Brain"},{"issue":"2","key":"10.4065\/mcp.2009.0649_bib50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.ajp.0000210957.39621.b2","article-title":"Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study","volume":"23","author":"Rauck","year":"2007","journal-title":"Clin J Pain"},{"issue":"8","key":"10.4065\/mcp.2009.0649_bib51","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jpain.2009.01.322","article-title":"Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial","volume":"10","author":"Shaibani","year":"2009","journal-title":"J Pain"},{"issue":"5","key":"10.4065\/mcp.2009.0649_bib52","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/AJP.0b013e318196d2b6","article-title":"Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens","volume":"25","author":"Wymer","year":"2009","journal-title":"Clin J Pain"},{"key":"10.4065\/mcp.2009.0649_bib53","author":"UCB, Inc."},{"key":"10.4065\/mcp.2009.0649_bib54","doi-asserted-by":"crossref","unstructured":"Hidv\u00e9gi T, Bretschneider B, Thierfelder S, Sommerville K, Bongardt S. Long-term efficacy of lacosamide in subjects with diabetic neuropathic pain: results of a double-blind, randomized withdrawal trial. Presented at: 27th annual meeting of the American Pain Society; Tampa, FL; May 8-10, 2008.","DOI":"10.1016\/j.jpain.2008.01.125"},{"key":"10.4065\/mcp.2009.0649_bib55","author":"UCB, Inc."},{"issue":"2","key":"10.4065\/mcp.2009.0649_bib56","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.2009.973","article-title":"The need for improved access to FDA reviews","volume":"302","author":"O'Connor","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.4065\/mcp.2009.0649_bib57","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ejpain.2008.05.016","article-title":"Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial","volume":"13","author":"Shaibani","year":"2009","journal-title":"Eur J Pain"},{"issue":"2","key":"10.4065\/mcp.2009.0649_bib58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0304-3959(90)91157-E","article-title":"The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms","volume":"42","author":"Sindrup","year":"1990","journal-title":"Pain"},{"issue":"5","key":"10.4065\/mcp.2009.0649_bib59","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/clpt.1992.183","article-title":"The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy","volume":"52","author":"Sindrup","year":"1992","journal-title":"Clin Pharmacol Ther"},{"issue":"19","key":"10.4065\/mcp.2009.0649_bib60","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJM199205073261904","article-title":"Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy","volume":"326","author":"Max","year":"1992","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/mcp.2009.0649_bib61","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pain.2008.04.012","article-title":"Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial","volume":"139","author":"Otto","year":"2008","journal-title":"Pain"},{"issue":"13","key":"10.4065\/mcp.2009.0649_bib62","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.4065\/mcp.2009.0649_bib63","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejpain.2007.12.010","article-title":"Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients","volume":"12","author":"Hanna","year":"2008","journal-title":"Eur J Pain"},{"key":"10.4065\/mcp.2009.0649_bib64","unstructured":"Zin CS, Nissen LM, O'Callaghan JP, Duffull SB, Smith MT, Moore BJ. A randomized controlled trial of oxycodone vs placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin [published online ahead of print December 2, 2009]. J Pain. doi:10.1016\/j. jpain.2009.09.003."},{"issue":"3","key":"10.4065\/mcp.2009.0649_bib65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000186502","article-title":"Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study","volume":"61","author":"Gatti","year":"2009","journal-title":"Eur Neurol"},{"issue":"9697","key":"10.4065\/mcp.2009.0649_bib66","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(09)61081-3","article-title":"Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial","volume":"374","author":"Gilron","year":"2009","journal-title":"Lancet"},{"issue":"7","key":"10.4065\/mcp.2009.0649_bib67","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1185\/03007990903048078","article-title":"Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy","volume":"25","author":"Baron","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.4065\/mcp.2009.0649_bib68","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.diabres.2008.12.018","article-title":"Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study","volume":"83","author":"Agrawal","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.4065\/mcp.2009.0649_bib69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S1748232107000080","article-title":"Randomized clinical trials of pregabalin for neuropathic pain: methods, results, and implications","volume":"3","author":"Dworkin","year":"2008","journal-title":"Progr Neurotherapeutics Neuropsychopharmacol"},{"issue":"1-2","key":"10.4065\/mcp.2009.0649_bib70","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pain.2006.10.029","article-title":"Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain","volume":"130","author":"Khoromi","year":"2007","journal-title":"Pain"},{"issue":"4","key":"10.4065\/mcp.2009.0649_bib71","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0404.2004.00338.x","article-title":"Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials","volume":"110","author":"Thienel","year":"2004","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"10.4065\/mcp.2009.0649_bib72","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0404.2006.00631.x","article-title":"Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study","volume":"113","author":"Beydoun","year":"2006","journal-title":"Acta Neurol Scand"},{"issue":"9","key":"10.4065\/mcp.2009.0649_bib73","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.clinthera.2007.09.023","article-title":"A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis","volume":"29","author":"Breuer","year":"2007","journal-title":"Clin Ther"},{"issue":"4","key":"10.4065\/mcp.2009.0649_bib74","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jpainsymman.2006.12.015","article-title":"Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain","volume":"34","author":"Silver","year":"2007","journal-title":"J Pain Symptom Manage"},{"issue":"1-2","key":"10.4065\/mcp.2009.0649_bib75","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pain.2006.09.040","article-title":"Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized double-blind, placebo-controlled studies","volume":"128","author":"Vinik","year":"2007","journal-title":"Pain"},{"key":"10.4065\/mcp.2009.0649_bib76","unstructured":"Simpson DM, Schifitto G, Clifford DB, et al. 1066 HIV Neuropathy Study Group. Pregabalin in the treatment of painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Poster presented at: 61st Annual Meeting of the American Academy of Neurology, Seattle, WA; April 29, 2009."},{"key":"10.4065\/mcp.2009.0649_bib77","series-title":"Phase II results for GSK1838262 (XP13512) reported for neuropathic pain associated with diabetic peripheral neuropathy","author":"XenoPort, Inc.","year":"2009"},{"issue":"2","key":"10.4065\/mcp.2009.0649_bib78","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pain.2008.08.017","article-title":"Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards","volume":"139","author":"Rice","year":"2008","journal-title":"Pain"},{"issue":"3","key":"10.4065\/mcp.2009.0649_bib79","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pain.2004.10.007","article-title":"Pharmacological treatment of peripheral neuropathic conditions based on shared commonalities despite multiple etiologies","volume":"113","author":"Hansson","year":"2005","journal-title":"Pain"},{"issue":"6","key":"10.4065\/mcp.2009.0649_bib80","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/WNL.51.6.1682","article-title":"A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection","volume":"51","author":"Kieburtz","year":"1998","journal-title":"Neurology"},{"issue":"18","key":"10.4065\/mcp.2009.0649_bib81","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/jama.280.18.1590","article-title":"Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial","volume":"280","author":"Shlay","year":"1998","journal-title":"JAMA"},{"issue":"5","key":"10.4065\/mcp.2009.0649_bib82","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/00126334-200412150-00010","article-title":"A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy","volume":"37","author":"Estanislao","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.4065\/mcp.2009.0649_bib83","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/13550280600873835","article-title":"A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy","volume":"12","author":"Schifitto","year":"2006","journal-title":"J Neurovirol"},{"issue":"1-2","key":"10.4065\/mcp.2009.0649_bib84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3959(02)00047-7","article-title":"Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy","volume":"98","author":"Hammack","year":"2002","journal-title":"Pain"},{"issue":"1","key":"10.4065\/mcp.2009.0649_bib85","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpainsymman.2007.02.043","article-title":"Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms","volume":"35","author":"Kautio","year":"2008","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"10.4065\/mcp.2009.0649_bib86","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/cncr.23008","article-title":"Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3)","volume":"110","author":"Rao","year":"2007","journal-title":"Cancer"},{"key":"10.4065\/mcp.2009.0649_bib87","author":"Pfizer, Inc."},{"issue":"12","key":"10.4065\/mcp.2009.0649_bib88","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jpain.2005.08.002","article-title":"Topiramate in chronic lumbar radicular pain","volume":"6","author":"Khoromi","year":"2005","journal-title":"J Pain"},{"issue":"9","key":"10.4065\/mcp.2009.0649_bib89","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1468-1331.2007.01916.x","article-title":"EFNS guidelines on neurostimulation therapy for neuropathic pain","volume":"14","author":"Cruccu","year":"2007","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.4065\/mcp.2009.0649_bib90","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1212\/01.WNL.0000137341.89781.14","article-title":"Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects","volume":"63","author":"Raskin","year":"2004","journal-title":"Neurology"},{"issue":"12(suppl 4)","key":"10.4065\/mcp.2009.0649_bib91","first-page":"S7","article-title":"Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain","volume":"65","author":"Dworkin","year":"2005","journal-title":"Neurology"},{"issue":"12(suppl 4)","key":"10.4065\/mcp.2009.0649_bib92","first-page":"S32","article-title":"Methodological issues in clinical trials of opioids for chronic pain","volume":"65","author":"Katz","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.4065\/mcp.2009.0649_bib93","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.pain.2008.06.024","article-title":"Placebo response in neuropathic pain trials","volume":"138","author":"Quessy","year":"2008","journal-title":"Pain"},{"issue":"9","key":"10.4065\/mcp.2009.0649_bib94","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/AJP.0b013e3181b12dec","article-title":"Enriched enrollment randomized withdrawal trial designs for analgesics","volume":"25","author":"Katz","year":"2009","journal-title":"Clin J Pain"},{"issue":"2","key":"10.4065\/mcp.2009.0649_bib95","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain"},{"issue":"7132","key":"10.4065\/mcp.2009.0649_bib96","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/bmj.316.7132.690","article-title":"Interpreting treatment effects in randomised trials","volume":"316","author":"Guyatt","year":"1998","journal-title":"BMJ"},{"issue":"3","key":"10.4065\/mcp.2009.0649_bib97","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pain.2009.08.019","article-title":"Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations","volume":"146","author":"Dworkin","year":"2009","journal-title":"Pain"},{"issue":"16","key":"10.4065\/mcp.2009.0649_bib98","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/archinte.159.16.1931","article-title":"Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic neuropathy pain","volume":"159","author":"Morello","year":"1999","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.4065\/mcp.2009.0649_bib99","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5414\/CPP44358","article-title":"Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial\u2014the GONIP trial","volume":"44","author":"Chandra","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"10.4065\/mcp.2009.0649_bib100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00044011-200929040-00002","article-title":"Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial","volume":"29","author":"Baron","year":"2009","journal-title":"Clin Drug Investig"},{"issue":"7","key":"10.4065\/mcp.2009.0649_bib101","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1185\/03007990903047880","article-title":"5% Lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study","volume":"25","author":"Baron","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"10.4065\/mcp.2009.0649_bib102","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.apmr.2007.07.038","article-title":"Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury","volume":"88","author":"Rintala","year":"2007","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"10.4065\/mcp.2009.0649_bib103","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejpain.2009.02.008","article-title":"Toward a definition of pharmacoresistant neuropathic pain","volume":"13","author":"Hansson","year":"2009","journal-title":"Eur J Pain"},{"key":"10.4065\/mcp.2009.0649_bib104","series-title":"Randomised Controlled Trials: Questions, Answers and Musings","author":"Jadad","year":"2007"},{"issue":"22","key":"10.4065\/mcp.2009.0649_bib105","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"9522","key":"10.4065\/mcp.2009.0649_bib106","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0140-6736(06)68700-X","article-title":"Persistent postsurgical pain: risk factors and prevention","volume":"367","author":"Kehlet","year":"2006","journal-title":"Lancet"},{"issue":"6","key":"10.4065\/mcp.2009.0649_bib107","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/0003-4819-140-8-200404200-00010","article-title":"Pain: moving from symptom control toward mechanism-specific pharmacologic management","volume":"140","author":"Woolf","year":"2004","journal-title":"Ann Intern Med"},{"issue":"12(suppl 4)","key":"10.4065\/mcp.2009.0649_bib108","first-page":"S66","article-title":"Mechanisms of neuropathic pain and their implications for the design of clinical trials","volume":"65","author":"Rowbotham","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.4065\/mcp.2009.0649_bib109","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1090-3801(03)00051-X","article-title":"Difficulties in stratifying neuropathic pain by mechanisms","volume":"7","author":"Hansson","year":"2003","journal-title":"Eur J Pain"},{"issue":"3","key":"10.4065\/mcp.2009.0649_bib110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values","volume":"123","author":"Rolke","year":"2006","journal-title":"Pain"},{"issue":"1","key":"10.4065\/mcp.2009.0649_bib111","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpain.2005.02.003","article-title":"Quantitative sensory testing: a comprehensive protocol for clinical trials","volume":"10","author":"Rolke","year":"2006","journal-title":"Eur J Pain"},{"issue":"4","key":"10.4065\/mcp.2009.0649_bib112","doi-asserted-by":"crossref","first-page":"e1000047","DOI":"10.1371\/journal.pmed.1000047","article-title":"A novel tool for the assessment of pain: validation in low back pain","volume":"6","author":"Scholz","year":"2009","journal-title":"PLoS Med"},{"issue":"4","key":"10.4065\/mcp.2009.0649_bib113","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00002508-199012000-00002","article-title":"Customizing treatment for chronic pain patients: who, what and why?","volume":"6","author":"Turk","year":"1990","journal-title":"Clin J Pain"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611602851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611602851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:25:20Z","timestamp":1758417920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611602851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":113,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0025619611602851"],"URL":"https:\/\/doi.org\/10.4065\/mcp.2009.0649","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4065\/mcp.2009.0649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}